Timing, Mechanisms, and Severity Patterns Timing is a key factor when evaluating possible skin reactions from GLP-1 therapy
Only a small number of GLP-1 medications are FDA-approved specifically for weight lossothers are typically used for type 2 diabetes management
These study designs illustrate that the weight loss outcomes reported in these trials reflect a pharmacologic effect in addition to structured lifestyle support
Structured tapering : When goals are met, we help members come off medication without weight regain
Until then, consultation with an exercise physiologist or strength trainer may be beneficial for many individuals to establish general strength assessment, implement a resistance program (trainer, class, or self-directed), and monitor over time
Even minor mistakes could lead to serious consequences